Select a Region

North America

Newscenter

Your hub for company news and information

EVERSANA

Posted on May 17, 20225/17/22

Four EVERSANA Leaders Named to 2022 PM360 ELITE 100

Posted on April 28, 20224/28/22

EVERSANA™ and Vector Pharma FZCO Announce Strategic Partnership to Expand Commercialisation Services Throughout Middle East and North Africa

EVERSANA

Posted on April 27, 20224/27/22

EVERSANA Announces European Expansion with New Location in the United Kingdom

Posted on April 14, 20224/14/22

EVERSANA and UpScriptHealth Announce Integrated, Direct-to-Patient Platform, Transforming the Patient Journey to Accelerate Therapy Access, Affordability and Adherence

Posted on March 22, 20223/22/22

EVERSANA’s Data & Analytics Platform ACTICS by EVERSANA Named a 2022 Artificial Intelligence Award Winner

Posted on March 17, 20223/17/22

EVERSANA unveils global price and market access solution NAVLIN by EVERSANA

EVERSANA

Posted on February 28, 20222/28/22

Rare Disease Day 2022: A Message from EVERSANA CEO Jim Lang

EVERSANA

Posted on February 23, 20222/23/22

EVERSANA™ MANAGEMENT CONSULTING Named a Best Boutique Consulting Firm by Vault

Posted on February 16, 20222/16/22

THREAD and EVERSANA Announce Industry’s First Integrated, Decentralized Registry and Real-World Data (RWD)-Driven Evidence and Commercialization Solution

Posted on February 3, 20222/3/22

EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World Evidence & Technology Platforms